NCT06610396

Brief Summary

This protocol seeks to analyze patient adherence and outcomes after monitored exercise sessions utilizing primarily weighted sled pushes and pulls for linearly progressed resistance training of individuals who have been diagnosed with cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
4mo left

Started Jun 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jun 2024Sep 2026

Study Start

First participant enrolled

June 18, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2026

Last Updated

February 26, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

September 20, 2024

Last Update Submit

February 24, 2025

Conditions

Keywords

exerciseresistance training

Outcome Measures

Primary Outcomes (3)

  • Change in Adipose Tissue (InBody, kg)

    Change in adipose tissue (kg) pre and post resistance training regimen measured via InBody 970 bioelectrical impedance analysis

    Baseline and study completion, up to 6 months.

  • Change in Adipose Tissue (Ultrasound, Lbs)

    Change in adipose tissue (pounds) pre and post resistance training regimen measured via ultrasound.

    Baseline and study completion, up to 6 months.

  • Change in Muscle Mass

    Changes in percent muscle mass (measured by InBody bioelectrical impedance analysis) and percent fat-free mass (measured by ultrasound) from baseline to six months

    Baseline and study completion, up to 6 months.

Secondary Outcomes (12)

  • Intervention Compliance Rate during Exercise Program (Adherence)

    Through study completion, up to 6 months.

  • Feasibility of the Exercise Program

    Through study completion, up to 6 months.

  • Adverse Events (Safety)

    Through study completion, up to 6 months.

  • Changes in Timed Up and Go Test Performance at baseline and post-exercise assessment

    Baseline and study completion, up to 6 months.

  • Changes in Functional Mobility Score at baseline and post-exercise assessment

    Baseline and study completion, up to 6 months.

  • +7 more secondary outcomes

Eligibility Criteria

Age20 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals diagnosed with cancer on an exercise program at the AHN Exercise Oncology and Resiliency Center

You may qualify if:

  • Age 20-89 years
  • Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study.
  • Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI and must be able to stand.
  • Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel. Any individuals not deemed safe to participate in the basic EOC exercise program will be referred to physical therapy or elsewhere

You may not qualify if:

  • Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program
  • Individuals deemed able to engage in more intense resistance training utilizing compound movements will not be eligible
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212, United States

RECRUITING

MeSH Terms

Conditions

NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Colin Champ, MD

    AHN Radiation Oncology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Trials Contact

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Radiation Oncologist

Study Record Dates

First Submitted

September 20, 2024

First Posted

September 24, 2024

Study Start

June 18, 2024

Primary Completion (Estimated)

June 18, 2026

Study Completion (Estimated)

September 18, 2026

Last Updated

February 26, 2025

Record last verified: 2025-02

Locations